Philips debuts innovations in ultrasound and enterprise informatics to advance cardiac care at ESC 2019
29 Agosto 2019 - 3:00AM
Philips debuts innovations in ultrasound and enterprise informatics
to advance cardiac care at ESC 2019
August 29, 2019
- European debut of latest release of Philips EPIQ CVx cardiology
ultrasound platform extends advanced automation capabilities to
make exams faster and easier to conduct
- Philips IntelliSpace Cardiovascular informatics platform
incorporates LindaCare’s OnePulse to streamline in-hospital and
remote follow-up care for patients with cardiac implantable
electronic devices
Paris, France – Royal Philips (NYSE: PHG, AEX:
PHIA), a global leader in health technology, is showcasing its
latest cardiac care innovations at the ESC Congress 2019 (Paris,
France, August 31 – September 4). At the congress, Philips is
showcasing Release 5.0 of its EPIQ CVx cardiology platform for the
first time in Europe. The platform includes automated applications
for 2D assessment of the heart, as well as robust 3D right
ventricle volume and ejection fraction measurements, making
accurate exams faster and easier to conduct [1]. Philips also
announced that it is collaborating with digital health company
LindaCare to combine the company’s innovative OnePulse™ cloud-based
solution for the remote monitoring of patients with cardiac
implantable electronic devices (CIEDs) with the Philips
IntelliSpace Cardiovascular informatics platform.
“Monitoring and follow-up of cardiac arrhythmia patients with
CIEDs can be often complex, with data trapped in different silos
that need to be reviewed individually,” said Calum Cunningham,
Business Leader for Enterprise Diagnostic Informatics at Philips.
“LindaCare’s innovative OnePulse solution consolidates this data,
and by incorporating OnePulse into our IntelliSpace Cardiovascular
platform, caregivers can see this additional information as part of
the broader cardiovascular history of each patient, allowing them
to make the most appropriate treatment decisions for each
patient.”
Philips IntelliSpace Cardiovascular is a web-based image and
workflow management platform which streamlines the workflow of
cardiology departments and across hospitals by consolidating
multi-modality images and data and enabling access to an open
ecosystem of cardiovascular software applications. The seamless
combination of IntelliSpace Cardiovascular with LindaCare’s
OnePulse solution allows clinicians to more easily access data from
their patients’ CIEDs remotely. This results in a more seamless
overall workflow, including alert management and triaging,
supporting more proactive care. Philips is also introducing a new
module on IntelliSpace Cardiovascular which complements the remote
monitoring workflow by automating, standardizing and streamlining
reporting for patients with CIEDs during hospital visits. Both the
OnePulse interface and the new module will be available on the
platform later this year. Since 2018, Philips has owned a minority
interest in LindaCare through Philips Health Technology Ventures,
which manages a business-agnostic digital health fund investing
capital in future partners to help drive Philips’ digital
transformation and jointly achieve the Quadruple Aim in
healthcare.
Increasing diagnostic confidence with the EPIQ CVx
cardiology ultrasound platformAt the ESC Congress 2019
Philips is also highlighting the new advanced automation
capabilities available on the EPIQ CVx cardiology ultrasound
platform. By incorporating advanced automation, there is less
variability between scans, leading to confident treatment decisions
which benefits patients. The new release of EPIQ CVx is a major
step forward, reducing the number of touches of the system by 21%
in each exam, which is equivalent to more than 400 exams each year
[2].
The AutoStrain LV application uses advanced
Automatic View Recognition technology to identify the different
views of the heart, providing exceptional visualization and
analysis of left ventricular function – extremely important
diagnostic information for patients at risk of developing
cardiovascular disease. Also new are the AutoStrain
LA and AutoStrain RV applications, which
automate the measurement of left atrial and right ventricular
longitudinal strain respectively. By creating reliable and
reproducible strain measurements for the left ventricle, left
atrium and right ventricle, the AutoStrain LV, LA and RV
applications support clinicians treating patients with atrial
fibrillation, arrhythmia and other complex heart conditions.
Enabling value-based cardiac careWith the shift
to value-based care, healthcare providers are increasingly focused
on balancing the need to provide the highest quality care with
managing their operational costs. Philips provides intelligent
solutions that help clinicians to be more efficient and effective,
enabling them to deliver a consistent standard of care, optimize
care pathways, simplify workflows and drive better treatment
outcomes.
The ESC Congress 2019 will take place at the Paris Expo Porte de
Versailles, France. Visit Philips at Stand #590. During the event,
Philips will host a Satellite Symposium on Ultrasound featuring
leading worldwide experts. For more information about the symposium
and other events, as well as general information about Philips’
presence at the show, visit www.philips.com/esc.
[1] The Philips EPIQ CVx and EPIQ CVxi 5.0 Diagnostic ultrasound
systems are available for sale globally. The AutoStrain LV, LA and
RV applications are CE marked and FDA cleared and available for
sale in Europe and in the USA. The AI enabled 3D AutoRV
application, designed using a Machine Learning-based algorithm, is
CE marked and FDA 510(k) pending, and is therefore available for
sale in Europe but is not available for sale in the USA.[2] Based
on eight scans per day over 48 weeks.
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel: +31 631 639 916Email:
mark.groves@philips.com Twitter: @mark_groves
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2018 sales of EUR 18.1 billion and
employs approximately 78,000 employees with sales and services in
more than 100 countries. News about Philips can be found
at www.philips.com/newscenter.
- Philips IntelliSpace Cardiovascular
- Philips EPIQ CVx R5
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024